MC1991A1 - PHARMACOLOGICALLY ACTIVE CARBOXYLIC ACID ESTERS - Google Patents

PHARMACOLOGICALLY ACTIVE CARBOXYLIC ACID ESTERS

Info

Publication number
MC1991A1
MC1991A1 MC882016A MC2016A MC1991A1 MC 1991 A1 MC1991 A1 MC 1991A1 MC 882016 A MC882016 A MC 882016A MC 2016 A MC2016 A MC 2016A MC 1991 A1 MC1991 A1 MC 1991A1
Authority
MC
Monaco
Prior art keywords
carboxylic acid
acid esters
pharmacologically active
active carboxylic
pharmacologically
Prior art date
Application number
MC882016A
Other languages
French (fr)
Inventor
Furlenmeier Andre
Hubschwerlen Christian
Montavon Marc
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MC1991A1 publication Critical patent/MC1991A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16—Nitrogen atoms
    • C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02—Preparation
    • C07D477/06—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • C07D477/08—Modification of a carboxyl group directly attached in position 2, e.g. esterification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D505/00—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
MC882016A 1987-11-24 1988-11-21 PHARMACOLOGICALLY ACTIVE CARBOXYLIC ACID ESTERS MC1991A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH457087 1987-11-24
CH316588 1988-08-25

Publications (1)

Publication Number Publication Date
MC1991A1 true MC1991A1 (en) 1989-11-30

Family

ID=25692354

Family Applications (1)

Application Number Title Priority Date Filing Date
MC882016A MC1991A1 (en) 1987-11-24 1988-11-21 PHARMACOLOGICALLY ACTIVE CARBOXYLIC ACID ESTERS

Country Status (14)

Country Link
EP (1) EP0318767A3 (en)
JP (1) JPH01165585A (en)
KR (1) KR890008082A (en)
AU (1) AU614793B2 (en)
DK (1) DK637888A (en)
FI (1) FI885330A (en)
HU (1) HU207522B (en)
IL (1) IL88403A0 (en)
MC (1) MC1991A1 (en)
NO (1) NO885221L (en)
NZ (1) NZ226989A (en)
PT (1) PT89080B (en)
SU (1) SU1598880A3 (en)
YU (2) YU216188A (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL113744A (en) * 1990-11-09 1998-06-15 Eisai Co Ltd 3-cephem derivatives and their preparation
MX9708422A (en) * 1995-05-03 1998-02-28 Smithkline Beecham Plc Esters of carbapenems.
JP2014525459A (en) * 2011-08-31 2014-09-29 マリンクロッド エルエルシー Remote assembly of targeted nanoparticles using H-phosphonate-ene / H-phosphonate-inhydrophosphonylation reaction
EP2862569A1 (en) 2011-09-09 2015-04-22 Cubist Pharmaceuticals, Inc. Methods for treating intrapulmonary infections
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
EP2893929A1 (en) 2013-03-15 2015-07-15 Cubist Pharmaceuticals, Inc. Ceftolozane antibiotic compositions
US20140274997A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Cephalosporin pharmaceutical compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
EP3043797B1 (en) 2013-09-09 2020-04-08 Merck Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2476087A1 (en) * 1980-02-18 1981-08-21 Roussel Uclaf NOVEL OXIMES DERIVED FROM 3-ALKYLOXY OR 3-ALKYL-THIOMETHYL 7-AMINO THIAZOLYL ACETAMIDO CEPHALOSPORANIC ACID, PROCESS FOR PREPARING THEM AND THEIR APPLICATION AS MEDICAMENTS
JPS5984889A (en) * 1982-11-05 1984-05-16 Sumitomo Chem Co Ltd Cephalosporin derivative and its preparation

Also Published As

Publication number Publication date
DK637888D0 (en) 1988-11-15
PT89080B (en) 1993-04-30
PT89080A (en) 1988-12-01
NO885221D0 (en) 1988-11-23
JPH01165585A (en) 1989-06-29
NZ226989A (en) 1992-05-26
FI885330A (en) 1989-05-25
KR890008082A (en) 1989-07-08
FI885330A0 (en) 1988-11-17
EP0318767A2 (en) 1989-06-07
EP0318767A3 (en) 1991-03-20
NO885221L (en) 1989-05-25
HUT48895A (en) 1989-07-28
YU216188A (en) 1990-04-30
HU207522B (en) 1993-04-28
SU1598880A3 (en) 1990-10-07
AU614793B2 (en) 1991-09-12
DK637888A (en) 1989-05-25
YU191589A (en) 1991-02-28
IL88403A0 (en) 1989-06-30
AU2578588A (en) 1989-05-25

Similar Documents

Publication Publication Date Title
DE3884517T2 (en) Biologically active carboxylic acid esters.
DK406686D0 (en) carboxylic acid derivatives
NO173547C (en) Analogous Procedures for the Preparation of Therapeutically Active Quinolone Carboxylic Acid Derivatives
IT1217573B (en) PHARMACOLOGICALLY ACTIVE SUBSTITUTED BENZAMIDS
MC1991A1 (en) PHARMACOLOGICALLY ACTIVE CARBOXYLIC ACID ESTERS
FR2609474B1 (en) PROCESS FOR THE ELECTROCHEMICAL SYNTHESIS OF CARBOXYLIC ACIDS
KR860700122A (en) Deglucoteicoplanin's carboxylic acid ester derivative
DK0464381T3 (en) 2-Methoximinocarboxylic acid esters
FR2602229B1 (en) PROCESS FOR THE PREPARATION OF UNSATURATED CARBOXYLIC ACID ESTERS
MC1981A1 (en) CATECHOL CARBOXYLIC ACID DERIVATIVES
BE893324A (en) PREPARATION OF CARBOXYLIC ACID ESTERS
FR2687667B1 (en) CARBOXYLIC ACID ESTERS OF HYDROXYPHENYLALCANOLS AS STABILIZERS.
IT8222566A0 (en) PHARMACOLOGICALLY ACTIVE URSOLIC ACID DERIVATIVE.
IT8820990A0 (en) PENEM ESTERS 6 REPLACED AS ANTI-INFLAMMATORY AND ANTIDEGENERATIVE AGENTS.
DK670589D0 (en) carboxylic acid derivatives
BE893322A (en) PREPARATION OF CARBOXYLIC ACIDS
FR2566434B1 (en) ELECTROSYNTHESIS OF CARBOXYLIC ACIDS
BE893419A (en) PRODUCTION OF CARBOXYLIC ACIDS AND ESTERS
DE69030774T2 (en) Optically active diastereoisomer salts of tetrahydro-2-furan carboxylic acid
FR2637594B1 (en) PREPARATION OF CARBOXYLIC ACID AMIDES
NZ223684A (en) Guanidine carboxylic acid esters and pharmaceutical compositions
DK576687A (en) THERAPEUTIC ACTIVE ALCOHIC ACID DERIVATIVES
NO932002D0 (en) NEW TIOSEMIC CARBONOIC ACID ESTERS
ZA888616B (en) Esters of pharmacologically active carboxylic acids
IL87072A0 (en) Biologically active carboxylic acid esters